Microbiology & Infectious Diseases

In October 2023, a confirmed local dengue case in Pasadena, California marked a concerning milestone for the state’s public health officials.

A recent study reveals that COVID-19 booster shots significantly reduce the risk of developing venous thrombosis or embolism (VTE) following SARS-CoV-2 infection.

An agreement has been issued by the United States Centers for Disease Control and Prevention (CDC) to partner with Alveo Technologies to develop a rapid, point-of-need diagnostic test for detecting avian influenza A(H5) in humans.

The U.S. Food and Drug Administration (FDA) has lifted a clinical hold on a late-stage trial of a combined COVID-19 and influenza vaccine candidate, allowing the study to resume following an investigation into a reported adverse event.

Rwanda has begun the 42-day countdown to officially declare an end to the Marburg virus outbreak, having discharged its last patient on November 8, 2024.

New research highlights the significant impact of Respiratory Syncytial Virus (RSV) vaccines in reducing severe respiratory illness among older adults, a group disproportionately affected by RSV.

Mpox outbreak cases outside Africa have been locally transmitted for the first time, with two new confirmed infections reported in the United Kingdom, according to the World Health Organization (WHO).

For the first time, bird flu has been detected in a pig in the United States, marking a significant event in the potential crossover of avian viruses to mammalian species.